Liliane Goetsch
44Patents
7h-index
19Co-inventors
62Inventor score
Filing activity: Dec 16, 2003 → Feb 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7241444B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 54 | Expired |
| US8329173B2 | Antibodies inhibiting c-Met dimerization and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US8545839B2 | Anti-c-Met antibody | Physics | 10 | Active |
| US9173962B2 | Antigen binding protein and its use as addressing product for the treatment of cancer | Physics | 9 | Active |
| US7553485B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US8361461B2 | Anti-IGF-IR antibodies and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US8071730B2 | Anti-JAM-A antibodies | Chemistry; Metallurgy | 7 | Active |
| US10202458B2 | IGF-1R antibody and its use as addressing vehicle for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US8124079B2 | Anti-IGF-IR antibodies and uses thereof | Human Necessities | 7 | Active |
| US8344112B2 | IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders | Physics | 6 | Active |
| US8765128B2 | Anti-cMET antibody | Chemistry; Metallurgy | 5 | Active |
| US9469691B2 | Anti-cMET antibody | Chemistry; Metallurgy | 5 | Active |
| US8741290B2 | Anti-cMet antibody | Chemistry; Metallurgy | 5 | Active |
| US7854930B2 | Anti-igf-ir antibodies and uses thereof | Human Necessities | 5 | Active |
| US8871909B2 | Antibodies inhibiting c-Met dimerization and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US8889832B2 | Antibodies inhibiting c-Met dimerization, and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US8729249B2 | Anti-cMET antibody | Chemistry; Metallurgy | 4 | Active |
| US8871910B2 | Antibodies inhibiting c-Met dimerization, and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US9107907B2 | Antibodies inhibiting c-Met dimerization, and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US8747850B2 | Anti-cMET antibody | Chemistry; Metallurgy | 4 | Active |
| US7914784B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US9011865B2 | Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US8673302B2 | Anti-cMet antibody and its use for the detection and the diagnosis of cancer | Chemistry; Metallurgy | 2 | Active |
| US8623359B2 | Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US9375425B2 | Combination of a C-Met antagonist and an aminoheteroaryl compound for the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.